CardioMed ApS: Financial statements 2024
CVR: 41760737
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
CardioMed ApS (CVR 41760737) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,172,240 and a net result of DKK 834,731 compared with DKK -2,674 the year before. Equity in the 2024 report amounted to DKK 883,343. The solvency ratio was 75.5%.
- Gross Profit
- DKK 1,172,240
- Profit/Loss
- DKK 834,731
- Equity
- DKK 883,343
- Total Assets
- DKK 1,169,623
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.2M | 835K | 883K | - |
| 2023 | - | -2K | -3K | 106K | 0 |
| 2022 | - | 258K | 199K | 289K | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
CardioMed ApS has published its annual report for 2023. Gross profit came to DKK -1,744, and the net result was DKK -2,674.
About CardioMed ApS
CardioMed ApS is a Danish company of the type Anpartsselskab based in Hasselager, founded in 2020. The company is registered under the industry Speciallægers aktiviteter. The management consists of Farhad Waziri. The company is owned by Waziri Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,779,651 and a net result of DKK 1,226,448 compared with DKK 834,731 the year before. Equity in the 2025 report amounted to DKK 1,987,791.